ICU Medical Inc
ICUI· Nasdaq
Filed Feb 27, 2024 · 10-K · 58 days after period end · 0000883984-24-000005
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 |
|---|---|---|---|---|
| Revenue | $587.86M | $578.01M | $340.53M | $318.05M |
| Net Income | -$17.15M | -$15.54M | $19.93M | $23.73M |
| EPS Diluted | — | — |
ICU Medical Inc · CIK 883984 · Engraved from SEC EDGAR
| — |
| $1.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2023 · filed Feb 27, 2024 · 58 d after period end